Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Related Articles by Review for PubMed (Select 17515401)

1.

Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene.

Goel A, Carlson SK, Classic KL, Greiner S, Naik S, Power AT, Bell JC, Russell SJ.

Blood. 2007 Oct 1;110(7):2342-50. Epub 2007 May 21.

2.
3.

Approaches to gene therapy with sodium/iodide symporter.

Spitzweg C, Morris JC.

Exp Clin Endocrinol Diabetes. 2001;109(1):56-9. Review.

PMID:
11573142
4.

Vesicular stomatitis virus as an oncolytic vector.

Barber GN.

Viral Immunol. 2004;17(4):516-27. Review.

PMID:
15671748
5.

Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.

Kogai T, Taki K, Brent GA.

Endocr Relat Cancer. 2006 Sep;13(3):797-826. Review.

6.

Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth.

Munguia A, Ota T, Miest T, Russell SJ.

Gene Ther. 2008 May;15(10):797-806. doi: 10.1038/gt.2008.45. Epub 2008 Mar 20. Review.

PMID:
18356812
7.

The importance of sodium/iodide symporter (NIS) for thyroid cancer management.

Carvalho DP, Ferreira AC.

Arq Bras Endocrinol Metabol. 2007 Jul;51(5):672-82. Review.

8.

Radiovirotherapy: principles and prospects in oncology.

Touchefeu Y, Franken P, Harrington KJ.

Curr Pharm Des. 2012;18(22):3313-20. Review.

PMID:
22397732
9.

The Na/I symporter (NIS): imaging and therapeutic applications.

Dadachova E, Carrasco N.

Semin Nucl Med. 2004 Jan;34(1):23-31. Review.

PMID:
14735456
10.

[Sodium iodide symporter in physiology and diseases -- the current state of knowledge].

Wolny M, Syrenicz A.

Endokrynol Pol. 2007 Nov-Dec;58(6):512-21. Review. Polish.

PMID:
18205108
11.

[The practical relevance of the sodium iodide symporter].

Spitzweg C.

Z Arztl Fortbild Qualitatssich. 2004 May;98 Suppl 5:25-32. Review. German.

PMID:
15255310
12.

In vivo imaging and tumor therapy with the sodium iodide symporter.

Dingli D, Russell SJ, Morris JC 3rd.

J Cell Biochem. 2003 Dec 15;90(6):1079-86. Review.

PMID:
14635183
13.

A perspective view of sodium iodide symporter research and its clinical implications.

Riesco-Eizaguirre G, Santisteban P.

Eur J Endocrinol. 2006 Oct;155(4):495-512. Review.

14.

Oncolytic virotherapy for multiple myeloma.

Stief AE, McCart JA.

Expert Opin Biol Ther. 2008 Apr;8(4):463-73. doi: 10.1517/14712598.8.4.463 . Review.

PMID:
18352850
15.

VSV-tumor selective replication and protein translation.

Barber GN.

Oncogene. 2005 Nov 21;24(52):7710-9. Review.

PMID:
16299531
16.
17.

The biology of the sodium iodide symporter and its potential for targeted gene delivery.

Hingorani M, Spitzweg C, Vassaux G, Newbold K, Melcher A, Pandha H, Vile R, Harrington K.

Curr Cancer Drug Targets. 2010 Mar;10(2):242-67. Review.

18.

Viral purging of haematological autografts: should we sneeze on the graft?

Thirukkumaran CM, Russell JA, Stewart DA, Morris DG.

Bone Marrow Transplant. 2007 Jul;40(1):1-12. Epub 2007 Apr 23. Review.

PMID:
17450184
19.

Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapy.

Baril P, Martin-Duque P, Vassaux G.

Br J Pharmacol. 2010 Feb;159(4):761-71. doi: 10.1111/j.1476-5381.2009.00412.x. Epub 2009 Oct 8. Review.

20.

Thyroid hormone biosynthesis - the importance of the sodium/iodide symporter (NIS).

Kraiem Z.

Pediatr Endocrinol Rev. 2003 Dec;1 Suppl 2:153-4; discussion 154. Review. No abstract available.

PMID:
16444152
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk